The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study

PURPOSE: To evaluate the safety of live attenuated influenza vaccine (LAIV) in children 2 through 17 years of age. METHODS: The study was conducted in 6 large integrated health care organizations participating in the Vaccine Safety Datalink (VSD). Trivalent LAIV safety was assessed in children who r...

詳細記述

保存先:
書誌詳細
出版年:Pharmacoepidemiol Drug Saf
主要な著者: Daley, Matthew F., Clarke, Christina L., Glanz, Jason M., Xu, Stanley, Hambidge, Simon J., Donahue, James G., Nordin, James D., Klein, Nicola P., Jacobsen, Steven J., Naleway, Allison L., Jackson, Michael L., Lee, Grace, Duffy, Jonathan, Weintraub, Eric
フォーマット: Artigo
言語:Inglês
出版事項: 2017
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437673/
https://ncbi.nlm.nih.gov/pubmed/29148124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.4349
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料